Philip S. Schein

8.4k citations
179 papers · 6.5k · 1 hit paper · h-index 48

Impact in

  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Viral-associated cancers and disorders
    • Lymphoma Diagnosis and Treatment

Papers in

    • Cancer Treatment and Pharmacology 16
    • Colorectal Cancer Treatments and Studies 15
    • Pancreatic and Hepatic Oncology Research 13
    • Cancer therapeutics and mechanisms 20

Philip S. Schein

171 papers receiving 5.6k citations

Philip S. Schein's Hit Papers

ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE 1975 · 368 citations
3680+17+34Years since publication100200300

Peers

Philip S. Schein
Comparison fields: 5 of 139
  • Oncology 2.4k
  • Pathology and Forensic Medicine 1.2k
  • Genetics 507
  • Hematology 426
  • Pulmonary and Respiratory Medicine 1.2k
Replace Kenneth R. Hande with:
Kenneth R. Hande United States
Morton K. Schwartz United States
William P. McGuire United States
Esteban Cvitkovic France
Robert F. Ozols United States
Étienne Chatelut France
Guy Laurent France
Jean‐Pierre Armand France
Alan V. Boddy United Kingdom
E Frei United States
Philip S. Schein relative to Kenneth R. Hande United States Kenneth R. Hande's profile →
Citations per field
00.5×1.5×2.0×
Kenneth R. Hande · 1×
Citations per year

Countries citing papers authored by Philip S. Schein

Since Specialization
Citations

This map shows the geographic impact of Philip S. Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Schein more than expected).

Fields of papers citing papers by Philip S. Schein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip S. Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Schein. The network helps show where Philip S. Schein may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip S. Schein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip S. Schein Line = papers co-authored together Philip S. Schein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE
Hit paper breakdown →
1975368
2 1976290
3 1989223
4
The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.
1967162
5 1975158
6 1982146
7 1973145
8
Liposomal protection of adriamycin-induced cardiotoxicity in mice.
1980139
9 1974134
10 1990124
11 1973117
12 1985117
13
Streptozotocin: depression of mouse liver pyridine nucleotides.
1968116
14
A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea.
1977106
15 1981105
16 1971103
17 198093
18 198090
19 197888
20
Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
198588

About Philip S. Schein

Philip S. Schein is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 179 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (20 papers), Cancer Treatment and Pharmacology (16 papers), Colorectal Cancer Treatments and Studies (15 papers), Neuroendocrine Tumor Research Advances (15 papers), Gastric Cancer Management and Outcomes (14 papers), Pancreatic and Hepatic Oncology Research (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Pancreatic function and diabetes (9 papers). The work is most often cited by research in Oncology (2.4k citations), Pathology and Forensic Medicine (1.2k citations), Genetics (507 citations), Hematology (426 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Philip S. Schein has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Vincent T. DeVita, Bruce A. Chabner, Paul V. Woolley, David A. Cooney, Frederick P. Smith, John S. Macdonald, Tom Anderson, Aquilur Rahman, Robert C. Young and Mary G. McMenamin. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Biochemical Pharmacology, Recent results in cancer research and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact